[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.237.138.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,251
Citations 0
Editorial
August 20, 2020

Robotic Surgery and Oncologic Outcomes

Author Affiliations
  • 1Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
JAMA Oncol. 2020;6(10):1537-1539. doi:10.1001/jamaoncol.2020.2996

In the 20 years since the US Food and Drug Administration (FDA) approved the use of Intuitive Surgical’s da Vinci surgical system for general laparoscopic surgery, robotic surgery has become commonplace in nearly every surgical specialty. This shift is likely owing to the technical advantages of robotic surgery vs conventional laparoscopy, including improved ergonomics, superior visual depth and definition, expanded articulation, elimination of motor tremor, and finer movements, despite the limited haptic feedback and potentially prohibitive cost to smaller centers. Although initial strides in robotic surgery were taken in benign disease, such as coronary artery surgery and the Lindbergh cholecystectomy, it was not long before robotics became widely adopted in surgical oncology. This trend started in urologic and gynecologic surgery. By comparison, application to head and neck surgery came later, with transoral robotic surgery (TORS) gaining FDA approval in December 2009. By that time, pelvic robotic surgery was already pervasive; in 2010, adoption of robotic surgery for radical prostatectomy was more than 40% in the United States.1

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×